The Significance of Octreotide in the Treatment of Mild to Moderate Acute Pancreatitis.

Authors

  • Dr. Linganagouda. S. Patil,Dr. Hanumanthappa. P. H.,Dr. Pooja. A. Reddy,Dr. Jayanth.M

Keywords:

Acute pancreatitis, Octreotide, Somatostatin analogue, Mild pancreatitis, Moderate pancreatitis

Abstract

Background:-Acute pancreatitis is a potentially life-threatening inflammatory disease of the pancreas with clinical manifestations ranging from mild self-limiting disease to severe systemicillness with multiorgan failure.[1] Octreotide, a long-acting somatostatin analogue,inhibits pancreatic exocrine secretion and has been used as an adjunct in themanagement of acute pancreatitis.[2]

References

1)Acute Pancreatitis Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012 revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111.

Downloads

Published

2026-07-20

How to Cite

Dr. Linganagouda. S. Patil,Dr. Hanumanthappa. P. H.,Dr. Pooja. A. Reddy,Dr. Jayanth.M. (2026). The Significance of Octreotide in the Treatment of Mild to Moderate Acute Pancreatitis . International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 884–890. Retrieved from https://ijprt.org/index.php/pub/article/view/2416

Issue

Section

Research Article